Daunomycin and mental status changes Patient Reports February 11, 2012

Daunomycin Side Effects Report #4771607-7
Daunomycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2005. Male patient, weighting 149.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: febrile neutropenia, fungal rash, jaundice , laboratory test abnormal, mental status changes, pharyngolaryngeal pain, respiratory disorder, systemic mycosis. Daunomycin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Daunomycin Side Effects Report #4633176-1
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 11, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, apnoea, hypermetabolism, hypoxia, lung infiltration, mental status changes, metabolic disorder , pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.

Daunomycin Side Effects Report #4652123-X
Daunomycin side effect was reported by a Consumer or non-health professional from on May 02, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, ammonia increased, apnoea, haemodialysis, hypermetabolism, hypoxia, mental status changes, pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.